Loading...

CareDx, Inc

CDNA•NASDAQ
Healthcare
Medical - Diagnostics & Research
$12.75
$-0.22(-1.70%)

CareDx, Inc (CDNA) Stock Overview

Explore CareDx, Inc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 77.0/100

Key Financials

Market Cap678.6M
P/E Ratio13.38
EPS (TTM)$1.05
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Week$19.10
1 Month$18.68
3 Months$30.93
1 Year Target$6.00

CDNA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CareDx, Inc (CDNA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.38 and a market capitalization of 678.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.25%
5-Day Change
-0.65%
1-Month Change
1.88%
3-Month Change
-22.01%
6-Month Change
-39.63%
Year-to-Date (YTD) Change
-14.36%
1-Year Change
99.03%
3-Year Change
-49.31%
5-Year Change
-12.65%
All-Time (Max) Change
103.65%

Contact Information

https://www.caredx.com
415 287 2300
1 Tower Place, South San Francisco, CA, 94080

Company Facts

644 Employees
IPO DateJul 17, 2014
CountryUS
Actively Trading

Frequently Asked Questions

;